Vesigen Therapeutics, Inc. Email Format

Biotechnology ResearchMassachusetts, United States2-10 Employees

Vesigen Therapeutics, Inc. is a biotechnology company focused on delivering therapeutics to intracellular targets through a scalable extracellular vesicle platform called ARMMs. This approach enables a range of payloads—RNA molecules, proteins, and genome-editing complexes—to be delivered directly into the cytoplasm of target cells, expanding the universe of druggable targets. The work is aimed at addressing unmet medical needs by enabling intracellular delivery that is difficult to achieve with traditional methods.

Based in Cambridge, Massachusetts, Vesigen operates in the biotechnology research sector with a small team. In 2023, Vesigen expanded its Scientific Advisory Board with the appointments of Connie Cepko, PhD, and Kate Fitzgerald, PhD. This development underscores the company's focus on advancing its ARMMs platform to enable new therapies.

Sign up for free to view info

Company overview Employee directory